Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November…
Clinical
OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the…
Commercial
BioSpace Movers & Shakers, Oct. 30
Commercial
Q32 Stays Busy with $60 Million Series B and First Dose…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Launch
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide…
Commercial
Oyster Point Pharma to Report Third Quarter 2020 Financial Results on…
Launch
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Trevena, Inc. Announces DEA Scheduling of OLINVYK (oliceridine) injection – FirstWord…
Home
Clinical
Launch
Launch
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Launch
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Thursday, November 5, 2020
Biospace News
-
November 5, 2020
Launch
Euro-Australian collaboration offers scalable solutions for biotech: announced at Bio-Europe 2020
Launch
Novo Nordisk’s operating profit increased by 6% in Danish kroner and by 7% at constant exchange rates (CER) in the first nine months of...
Launch
Euro-Australian collaboration offers scalable solutions for biotech: announced at Bio-Europe 2020
Launch
Freeline to present new data at the 12th Annual Protein and Antibody Engineering Summit
Launch
Idera Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update...
Globenewswire News
-
October 29, 2020
0
Launch
Novartis Acquires Vedere Bio, a Novel Optogenetics AAV Gene Therapy Company
-
October 29, 2020
0
Launch
Cibus Sharpens Corporate Focus to Concentrate on the Five Major Input...
Biospace News
-
October 29, 2020
0
Launch
Albireo Announces Presentations at NASPGHAN 2020 Annual Meeting Nasdaq:ALBO
Globenewswire News
-
October 23, 2020
0
Launch
BioSpace Movers & Shakers, Oct. 23
Biospace News
-
October 23, 2020
0
1
2
3
...
33
Page 1 of 33
- Advertisement -
MOST POPULAR
Acura Pharmaceuticals Provides an Update on the Development of LTX-03
January 2, 2020
EnGeneIC Announces First Patients with Advanced-Stage Pancreatic Cancer Dosed in Phase...
May 13, 2019
Menstrual Irregularity More Common in Women With Type 1 Diabetes: Presented...
March 26, 2019
Malaysia to work with UNICEF on polio vaccination in Sabah state...
December 15, 2019
Load more
HOT NEWS
Clinical
Govt revokes permit for gene therapy drug Invossa ...
Commercial
Alnylam to Webcast Presentation at 38th Annual J.P. Morgan Healthcare Conference
Phase I
?NeuClone Completes Dosing in Phase I Clinical Trial of Stelara (ustekinumab)...
Deals
CoImmune Inc., a US-based clinical-stage biotech, and Formula Pharmaceutical Inc. agree...
